Study of SHR-4375 for advanced solid tumors
Part of Cancer clinical trials.
This study tests a new experimental drug, SHR-4375, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective for these cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced solid tumors (cancer that has spread or cannot be removed) that have not responded to standard treatments, or you cannot take those treatments
- You are able to take care of yourself (ECOG score 0 or 1) and expected to live at least 12 weeks
- Your cancer can be measured with scans (like CT or MRI)
- You do not have untreated brain metastases or active autoimmune diseases
- You do not have active hepatitis B or C or a severe infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SHR-4610 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective, and may be an option if you have a measurable tumor and are generally in good health.
This study tests a new drug called SHR-8203 for people with advanced solid tumors that have stopped responding to standard treatments or have no treatment options. The goal is to see if the drug is safe and helps shrink or control the tumor.
This study tests a new drug called SHR-4375 combined with other cancer treatments for people with advanced solid tumors that haven't gotten better with standard care. The goal is to see if the combination is safe and works against the cancer.
This trial tests a new drug, SHR-4506, for people with advanced cancers that have stopped responding to standard treatments or cannot be treated with standard options. It aims to see if the drug is safe and helpful.
This study is testing a new drug called SHR-1049 for people with advanced solid tumors (cancers that have spread). It looks at safety, how the drug moves through the body, and whether it helps shrink tumors. You may be eligible if you have tried standard treatment without success or no standard treatment exists.
This trial is testing an investigational drug called SHR-7787 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if it is safe and how well it works. It may be an option if your tumor type is no longer responding to other treatments.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.